CNSX:BBM - Blueberries Medical Stock Price, Forecast & News

Blueberries Medical trades on the CNSX under the ticker symbol "BBM."

1 brokerages have issued twelve-month price targets for Blueberries Medical's shares. Their forecasts range from $0.47 to $0.47. On average, they anticipate Blueberries Medical's share price to reach $0.47 in the next twelve months. This suggests a possible upside of 370.0% from the stock's current price. View Analyst Price Targets for Blueberries Medical.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Blueberries Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Blueberries Medical.

News articles about BBM stock have been trending somewhat positive this week, according to InfoTrie. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Blueberries Medical earned a daily sentiment score of 0.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Blueberries Medical.

Some companies that are related to Blueberries Medical include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF) and CLS Holdings USA (CLSH).

Based on aggregate information from My MarketBeat watchlists, some companies that other Blueberries Medical investors own include Aurora Cannabis (ACB), BioMarin Pharmaceutical (BMRN), Cronos Group (CRON), Nlight (LASR), Apollo Global Management (APO), Cross Timbers Royalty Trust (CRT), McDermott International (MDR), Cannara Biotech (LOVE), Khiron Life Sciences (KHRN) and Heron Therapeutics (HRTX).

Shares of BBM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BBM stock can currently be purchased for approximately $0.10.

The official website for Blueberries Medical is http://www.blueberriesmed.com/.